Daniel T. Scavilla
Net Worth

Last updated:

What is Daniel T. Scavilla net worth?

The estimated net worth of Mr. Daniel T. Scavilla is at least $32,783,921 as of 21 Nov 2024. He owns shares worth $23,037 as insider, has earned $26,709,734 from insider trading and has received compensation worth at least $6,051,150 in Globus Medical, Inc..

What is the salary of Daniel T. Scavilla?

Mr. Daniel T. Scavilla salary is $864,450 per year as Executive Vice President, Chief Commercial Officer & Pres of Trauma in Globus Medical, Inc..

How old is Daniel T. Scavilla?

Mr. Daniel T. Scavilla is 60 years old, born in 1965.

What stocks does Daniel T. Scavilla currently own?

As insider, Mr. Daniel T. Scavilla owns shares in one company:

Company Title Shares Price per share Total value
Globus Medical, Inc. (GMED) Executive Vice President, Chief Commercial Officer & Pres of Trauma 400 $57.59 $23,037

What does Globus Medical, Inc. do?

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Daniel T. Scavilla insider trading

Globus Medical, Inc.

Mr. Daniel T. Scavilla has made 7 insider trades between 2018-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 130,000 units of GMED stock on 21 Nov 2024. As of 21 Nov 2024 he still owns at least 400 units of GMED stock.

Transaction Date Security Shares Price per share Total value Source
Option
Class A Common Stock 50,000 $43.77 $2,188,500
Sale
Class A Common Stock 130,000 $85 $11,050,000
Option
Class A Common Stock 80,000 $43.58 $3,486,400
Option
Stock Option (Right to Buy Class A Common Stock) 130,000 $43.68 $5,677,750
Option
Stock Option (Right to Buy Class A Common Stock) 30,000 $26.27 $788,100
Option
Class A Common Stock 30,000 $26.27 $788,100
Option
Stock Option (Right to Buy Class A Common Stock) 30,000 $43.77 $1,313,100
Option
Class A Common Stock 30,000 $43.77 $1,313,100
Sale
Class A Common Stock 60,000 $80.02 $4,801,200
Option
Stock Option (Right to Buy Class A Common Stock) 50,000 N/A N/A
Option
Class A Common Stock 100,000 N/A N/A
Sale
Class A Common Stock 100,000 $78.69 $7,869,000
Option
Stock Option (Right to buy Class A Common Stock) 50,000 N/A N/A
Sale
Class A Common Stock 100,000 N/A N/A
Option
Stock Option (Right to Buy Class A Common Stock) 100,000 N/A N/A
Option
Stock Option (Right to Buy Class A Common Stock) 100,000 $25.46 $2,546,000
Option
Class A Common Stock 100,000 $25.46 $2,546,000
Sale
Class A Common Stock 100,000 N/A N/A
Option
Class A Common Stock 100,000 N/A N/A
Sale
Class A Common Stock 50,540 $50 $2,527,000
Option
Class A Common Stock 81,790 $50 $4,089,500
Option
Stock Option (Right to Buy Class A Common Stock) 31,250 $50 $1,562,500
Option
Class A Common Stock 18,210 $25.4 $462,534
Option
Stock Option (Right to Buy Class A Common Stock) 18,210 $25.4 $462,534
Sale
Class A Common Stock 18,210 $25.4 $462,534

Globus Medical key executives

Globus Medical, Inc. executives and other stock owners filed with the SEC: